As more healthcare systems consider implementing a social determinants of health (SDoH) screening program to care for patients’ non-medical needs, we at Salud America! at UT Health San Antonio are sharing important tips in developing such a program. Today, we’re highlighting how often patients should be screened for social needs. While there is no evidence-based gold standard for how often screening should be conducted, lived experiences from clinics that have successfully implemented a SDoH screening program can help healthcare facilities make critical decisions in designing their own screening program. Let’s explore the lived experiences of several of these clinics today!
Considerations in Determining Screening Frequency
Initially, it may seem most effective to ...
UT Health San Antonio, including Dr. Amelie G. Ramirez, and seven regional collaborators will leverage $46 million from the National Institutes of Health (NIH) over the next five to seven years to translate scientific discoveries into therapeutic benefits for human health and well-being. A key focus will be reducing health disparities among Latinos (particularly Mexican Americans), active military personnel, and veterans. Dr. William L. Henrich, president of UT Health San Antonio, recently announced the funding from the NIH Clinical and Translational Science Awards (CTSA) Program. Henrich thanked partners including The University of Texas at Austin Dell Medical School and College of Pharmacy, The University of Texas at San Antonio and the Texas Biomedical Research Institute for ...
Researchers at The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio are recruiting participants for the VIVA-MIND study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems. Volunteers ages 50 to 89 with a diagnosis of mild cognitive impairment or probable mild Alzheimer’s may ask about eligibility for VIVA-MIND, said Dr. Sudha Seshadri, professor of neurology and director of the Glenn Biggs Institute. Half of volunteers will be given the new drug therapy, an oral pill called varoglutamstat. The other half will receive a placebo pill that looks just like the study drug. “The first people who will benefit from a new Alzheimer’s disease treatment are those who are ...
Dr. Amelie Ramirez, leader of Salud America! at UT Health San Antonio, has won the 2023 Association of American Cancer Institutes (AACI) Cancer Health Equity Award. The award recognizes exceptional leadership in promoting health equity, mitigating cancer disparities, and advocating for diversity and inclusion at a cancer center. Past winners are Dr. Robert A. Winn of the VCU Massey Cancer Center and Dr. Electra D. Paskett of Ohio State University. Ramirez, nominated by the award by former Mays Cancer Center Director Dr. Ruben Mesa, will be recognized at AACI's annual meeting Oct. 2, 2023. "I am honored to receive the AACI Cancer Health Equity Award. It recognizes the hard work we do at the Mays Cancer Center at UT Health San Antonio to promote health equity, study new ...
Researchers at UT Health San Antonio are launching a five-year, $15.5-million study to investigate why the region’s older Mexican Americans experience a high rate of dementia. The project, the San Antonio Mind and Heart Study, is led by UT Health San Antonio’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases with funding from the National Institutes of Health/National Institute on Aging. Let’s dive deeper Latinos, dementia, and the goals of this study.
A Continuation of Important Data
The new dementia study is an is an extension of the San Antonio Heart Study, conducted at UT Health San Antonio between 1979 and 2006 led Dr. Helen P. Hazuda. Researchers, led by Dr. Claudia L. Satizabal, associate professor of population health ...
CDC Project Firstline knows that healthcare workers are short on time, but this shouldn’t limit access to practical and valuable infection control training. That’s why CDC Project Firstline developed Infection Control Micro-Learns – a series of guided infection control discussions that can be easily incorporated into team meetings or huddles facilitated by an experienced team member with infection control expertise. These short and easy-to-understand learning opportunities can help healthcare workers recognize and minimize infection control risks to protect themselves, coworkers, and patients from infectious diseases. Let’s explore the Infection Control Micro-Learn on blood!
What to Do When You See Blood
As a healthcare worker, you will work with a variety of patients ...
One of the biggest contributors to climate change are gasoline-powered vehicles, which emit greenhouse gases that warm Earth’s atmosphere. In a positive step, our nation is shifting toward climate-friendly electric vehicles (EVs), which emit less greenhouse gasses than gasoline-powered cars, even when accounting for manufacturing and the electricity used for charging. But a new survey by Axios reveals disparities in EV accessibility, especially in the Latino population. How might these disparities impact Latino health and our nation’s fight against climate change?
How Do Latinos Feel About EVs?
According to the Axios survey, most Latinos (60%) say it’s important to shift to EVs to minimize climate change damage, but they expressed more interest in buying gas-powered ...
Although the COVID-19 state of emergency has ended, healthcare workers continue to encounter COVID-19 and other infectious diseases in the workplace. That’s why the Centers for Disease Control and Prevention’s Project Firstline provides all healthcare workers – no matter their role or educational background – the infection control training and resources they need to protect themselves, their patients, and their coworkers from infectious diseases. Now in its third year, CDC Project Firstline includes a diverse group of more than 80 healthcare, public health, academic, and state and local partners. In collaboration with the National Hispanic Medical Association, Salud America! is one of those partners. Today, to support CDC Project Firstline and our partners, we’re ...
Did you know Latinos are expected to face a 142% rise in cancer cases in coming years? To address the heavy burden of Latino cancer, you can register now for UT Health San Antonio's 4th biennial Advancing the Science of Cancer in Latinos conference Feb. 21-23, 2024, at the Marriott Riverwalk in San Antonio, Texas. The conference will welcome researchers, physicians, community leaders, patient advocates, policymakers, and students from across the country to tackle Latino cancer from prevention to treatment to survivorship. “Advancing the Science of Cancer in Latinos is a sanctuary where we can share research, experience, and action to translate basic research into clinical best practices, effective community interventions, and professional training programs to eliminate cancer ...
